Huma Appoints Kaushik Gune as Head of U.S. Healthcare Business to Promote Adoption of Digital Health Solutions
Earlier this year, Kaushik Gune joined Huma as our new Head of Healthcare (US). Kaushik has over 20 years of operational, financial and strategic experience in companies such as McKinsey & Co, NuVasive and United Airlines. Before joining Huma, Kaushik was responsible for building Smith+Nephew’s digital health business within the musculoskeletal space.
We spoke to Kaushik about his perspectives on the future challenges and opportunities for digital health companies in the US.
Could you tell us a bit about your background and how it led to your current position at Huma?
Over the last 20 years, I’ve worked across a number of high-profile companies in operations, finance, strategy and commercial roles, and I’m excited to be able to use my knowledge to support Huma to build its expertise and expand its offering in the US. During my time at Smith+Nephew, I bought and commercialised digital health technologies and helped shape the US reimbursement landscape through this work. This type of experience is critical to navigating the complexities of the US Healthcare system.
On my decision to join Huma, one of the biggest driving factors for me was the technology itself. Huma’s platform is incredibly versatile and has huge potential to be applied across disease states and used by different types of patients. The digital health sector has recently come under fire for a lack of clinical robustness. Seeing Huma’s investment in science and research, as well as care and attention to regulatory requirements, I believe Huma’s platform offers something very unique in the digital health space.
What are Huma’s ambitions for US healthcare?
We want to build on the success we’ve had in healthcare within the UK, Germany and the Middle East, to support people in the US to live longer fuller lives. We recently acquired AstraZeneca’s digital health platform, AMAZE. We are excited to be working with one of the largest biopharmaceutical companies and aim to leverage the strong foundations and early success of AMAZE to accelerate digital-first care. We’re also looking to secure other strategic partnerships like this in the US as we continue to scale.
Our vision is to become a top digital health player in the US, and to do this we believe it’s important to continue to expand and build our team in the US. We understand the importance of on-the-ground expertise, especially in healthcare, and believe it is essential for us to build our position as a trusted partner in the US.
You mention the importance of geographical expertise when it comes to healthcare. How does the US compare to other healthcare systems when it comes to digital-first care?
I think we’re starting to see the health system in the US evolve to become more integrated where hospitals and industry are now looking at healthcare from an overall disease management perspective rather than focusing on episode management. This is something we already see in other countries, where Huma operates such as the UK. As we move towards these new models of care, the role of digital health becomes increasingly important, helping to connect different services, and clinical pathways, to provide more holistic care for patients.
What are some of the big challenges digital health companies, like Huma, will need to address over the next few years?
Data privacy will continue to be a big challenge that digital health companies will have to get right. In the wake of Roe v. Wade, protecting health data will be an issue that’s top of mind for governments and regulators. Patients and the rights of patients have to be at the core of our thinking when it comes to data privacy. Once we have this starting point, we can begin to figure out how to structure data sharing and collaboration to maximize innovation.
Another important topic for the US specifically will be navigating reimbursement and the shift towards value-based care. We’ve taken some steps forward with this, with CMS recognising that things need to be done differently and that digital health technologies need to be reimbursed, but we still have a way to go. Clear pathways for reimbursement must be created. If reimbursement models continue to lag behind innovation, there’s a fear that companies developing innovative digital health tools and delivering real-world value could actually end up being punished.
As the digital health industry becomes more established, there’s also an additional challenge in terms of external demands from those using and regulating these technologies. As digital therapeutics are playing a greater role in diagnosing patients and managing health, it’s vital to collect robust evidence and provide assurance that it’s safe and appropriate. Companies will need to start putting clear evidence-generation strategies in place to support the scaling of digital health.
What’s your vision for the future of digital health?
We know that around 95% of care for chronic conditions happens outside the clinical setting, which is why digital health tools that can provide real-world insights into a patient’s health outside clinic visits are vital. At the moment this technology is largely just being used to gather data, but the ambition is to use these tools to deliver more personalised, proactive and predictive care. To realise this potential we will need to drive collaboration between stakeholders across the healthcare industry such as clinicians, technology companies and most importantly, patients. At Huma, we don’t have a “do it all yourself” vision but we truly believe in the importance of partnerships in supporting our goal to help people live longer fuller lives.
AI detects patients at highest risk of COVID-19 mortality
Peer-reviewed research published in Nature Scientific Reports
Atos and Huma support Symbiosis Hospital to expand care capacity
Huma’s ‘hospital at home’ technology will expand care capacity in Pune, India by up to 60%
Breaking the bias in cardiovascular disease
How digital-first care and research can address the gender bias in cardiovascular disease
Decentralized trial sees increased adherence to heart medication
A study testing if a cardiac trial could be run entirely remotely found rapid recruitment, high engagement and that patients with low baseline increased their medication adherence from 85% to 96%.
Digital support against Covid-19 in Germany
Press release: German states focus on patient care via app
Driving Patient Safety with Digital Technology
Patient safety may be paramount across healthcare, but we are a long way from ‘first, do no harm’. The World Health Organisation (WHO) reports that medication errors cause US$ 42 billion of global total health expenditure worldwide, 50% of the overall preventable harm in medical care.
FT 1000: Huma named Europe's fastest growing healthcare company
Press release: Huma listed in the Top 25 for all sectors
Fierce biotech webinar
Taking the "clinic" out of clinical trials and healthcare: Bridging research and care with digital tools
Fixing the foundations: building a solid evidence base for digital health
Our Global Clinical Directors Arrash Yassaee and Peter Kirpalani-Collins explain the importance of clinical rigour and evidence generation in digital health and how we’re doing things differently here at Huma.
HSJ Value Awards 2021
Huma has been shortlisted as a finalist for the HSJ Value Awards 2021.
How Huma technology can reduce burnout on virtual wards
Expectations are high when you hold people’s lives in your hands, so it is little wonder that physicians report emotional exhaustion and feeling overextended, plus a feeling of depersonalization.
How can digital solutions empower and support heart failure patients?
We launched a 12-week remote patient monitoring pilot with Cwm Taf and Betsi Cadwaladr University Health Boards
How decentralized and hybrid trials can drive efficiencies beyond the pandemic
Huma’s Nico O'Kuinghttons discusses how we can drive more efficient decentralized and hybrid clinical trials post-pandemic
How our digital CVD risk model can help reduce avoidable deaths
Our research was published in European Heart Journal Digital Health (EHJ-DH)
How to accelerate digital adoption across the UK healthcare system
We have only seen the tip of the iceberg when it comes to digital health. There is so much more that can be achieved with the adoption of remote patient monitoring - but how can we accelerate it?
How to design virtual wards: 5 tips to set you up for success
Our clinical deployment lead, Dr Terry Deeny shares his top tips for designing successful virtual ward programmes based on Huma’s experience supporting the NHS.
How we help tackle cardiac surgical waiting lists
We worked with Royal Brompton and Harefield hospitals to remotely monitor and prioritise deteriorating patients.
Huma Appoints Kaushik Gune as Head of U.S. Healthcare Business to Promote Adoption of Digital Health Solutions
Huma has appointed Kaushik Gune as the company’s new U.S. Head of Healthcare
Huma acquires iPLATO Healthcare to advance digital-first delivery of care
The two companies will combine their expertise to provide remote patient monitoring for NHS patients
Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care
Huma acquires AstraZeneca’s digital health platform AMAZE™ and AstraZeneca becomes a shareholder of Huma
Huma and RARE-X partner to accelerate research
Press release: RARE-X’s federated data platform will pair with Huma’s DCT platform to accelerate research
Huma and Tamer bring digital ‘hospital at home’ platform to the Kingdom of Saudi Arabia
Tamer will bring Huma’s ‘hospitals at home’ technology to the Kingdom of Saudi Arabia to tackle diabetes and cardiovascular disease.
Huma announces US expansion
Press release: Experienced industry leaders create founding US Huma team
Huma appoints Shahram Sharif as Chief Business Officer - Medtech to accelerate digital-first use in the medtech industry
Sharif joins Huma to lead business development activities for digital companion app product
Huma calls for safeguarding of scientific collaboration
CEO & Founder Dan Vahdat speaks at World Economic Forum event in Davos.
Huma collaborates with Bayer to advance precision treatment for lung cancer
Medical technology powered using artificial intelligence
Huma finds way to measure breathing rate using entry-level smartphone gyroscopes
Huma researchers have verified a way to measure breathing rate using the gyroscopes in entry-level smartphones.
Huma joins forces with independent healthcare provider to launch virtual ward service for the NHS
Huma and Xyla Elective Care will work together to deliver tech-enabled virtual wards for the NHS
Huma raises $130 million financing to scale its digital health platform for better care and research
Leading names in health and technology fund expansion
Huma wins prestigious Prix Galien USA 2021 award
Huma’s remote patient monitoring technology is awarded ‘pharma’s Nobel Prize’
Huma wins ‘best of the best’ Prix Galien International 2022 award
Huma has won the Prix Galien International 2022 ‘best of the best digital health product’ award for the impact of its remote patient monitoring platform across healthcare and research.
Huma’s collaborative Covid-19 project wins HSJ Value Award
Our teams enabled better patient care and doubled clinical capacity with our hospital at home technology.
Huma’s peer-reviewed research links bedtime with heart health
Our peer-reviewed research explored the link between time of sleep and risk of cardiovascular disease in over 88,000 people
Increasing clinical trial success rates with adaptive technology
Overall, adaptive trials are more efficient, take less time to complete, and need fewer participants. By allowing for pre-planned modifications to a trial’s design after it has begun, adaptive trials make much better use of resources and money.
Keeping patients safe at home with virtual wards
Digital health has an important role to play in reducing patient harm and improving safety. This blog explores some of the key challenges, insights and learnings that enable safer patient care when using digital technology.
Key themes from this year's MedTech Conference 2022
MedTech Conference 2022, in Boston, one of MedTech’s leading annual events, has wrapped up, and we caught up with our Huma MedTech team to get the low down on all the industry buzz from this year's show.
Mediclinic Middle East launches Mediclinic at Home
A new remote care monitoring system for patients suffering from chronic conditions
Microsoft White Paper: Trends Shaping the Future of Clinical Trials
Microsoft explores the future of clinical trials and how decentralization, using tools like Huma’s, could be the key to shaping their future.
NHS Long Term Plan Webinar Series
How digital technology is helping to battle the growing waiting list backlog
Pharma and digital health must join forces for patients
Dan Vahdat, CEO and Founder of Huma, discusses how we are working with pharma partners to improve clinical outcomes through digital health solutions.
Powering COVID-19 virtual wards for better patient outcomes
Researchers have found that COVID-19 mortality rates were up to four times lower and hospital stays decreased by forty percent with Huma’s technology¹.
Remote patient monitoring pilot shortlisted for two prestigious HSJ Awards
The project has been nominated in the ‘Digitising Patient Care’ category at the HSJ Awards and ‘Virtual or Remote Care Initiative of the Year’ category at the HSJ Patient Safety Awards.
Smith+Nephew partner with Huma
Press release: Smith+Nephew and Huma develop RPM app to assist the restart of UK orthopaedic surgery
Taking the ‘clinic’ out of clinical trials
Bridging research and care with digital tools
Ten highlights from 2021, our 10th anniversary year
How we’re helping ~two million users across our platforms and people around the world live longer, fuller lives
Three ways that digital-first care can improve patient safety
During the COVID-19 pandemic the public were under quarantine orders preventing many patients from seeking care. A study on remote-patient monitoring showed that digital-first care provided a safe and effective option for patients with COVID-19.
Virtual Wards vital to help NHS tackle ‘substantial’ pressures
Huma welcome the Government’s announcement to accelerate the roll out of digital technology to provide an extra 2,500 virtual ward ‘beds’¹.
Webinar: Advancing digital-first delivery of care
Huma and iPLATO (myGP) hosted a joint webinar on how we can bring digital-first care to patients at scale
Webinar: Bridging the digital divide for improved patient diversity
Huma joined leading industry experts for a Reuters Events webinar on fostering diversity in decentralized and hybrid clinical trials
Webinar: Bringing the hospital home via digital virtual wards
Watch our webinar with leaders from the NHS and the AHSH Network.
Webinar: Empowering patients and relieving pressure on the NHS
Learn how Huma’s technology helps clinicians improve outcomes for heart failure patients and identify deteriorating cardiac surgery patients with almost 90% specificity
What Huma has learned from COVID-19
Three important lessons on how COVID-19 is shaping modern medicine
Why we acquired iPLATO (myGP)
Huma & iPLATO (myGP) join to create new possibilities in healthcare and research
World Patient Safety Day: supporting medicine safety with digital tools
For World Patient Safety Day in 2022, our Global Clinical Director Peter Kirpalani-Collins explains how digital healthcare tools can help keep patients safe by monitoring their symptoms and medication use.